Allogene Therapeutics Inc.:终止协议未涉及任何解约付款——根据SEC文件披露

美股速递
May 14

根据一份提交给美国证券交易委员会的文件显示,生物技术公司Allogene Therapeutics Inc.在其终止协议的执行过程中,并未支付任何形式的解约款项。这一披露明确了相关财务安排,避免了潜在的费用支出。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10